# FDA warns of vision-loss risk linked to popular GLP-1 drugs such as Wegovy and Zepbound

https://mins.news/en/item/136836

- CNBC, 2026-11-10 07:52 UTC
- Health
- Original: https://www.cnbc.com/2026/11/10/fda-warning-vision-loss-glp1-wegovy-zepbound.html

> The FDA says it has found evidence of a potential increase in the risk of a rare eye condition associated with GLP-1 drugs used for weight management and diabetes, including drugs such as Wegovy and Zepbound.

## Related coverage

- [FDA orders new eye-condition warning for Ozempic, Wegovy and other GLP-1 drugs](https://mins.news/en/video/137832) — ABC News, 2026-11-10
- [Makers of GLP-1 drugs ordered to warn of rare eye condition](https://mins.news/en/item/137917) — BBC News, 2026-11-10
- [FDA warns GLP-1 drugs may raise risk of rare vision-loss condition](https://mins.news/en/item/137517) — Ars Technica, 2026-11-10
